Table 1.

Patient characteristics undergoing initial ¹⁸F-FDG PET/MR and of the different investigated subgroups

	All included patients (n=39)	Subgroup with 99mTc-sestamibi SPECT (n=23)	Subgroup with follow-up MRI (n=29)	Subgroup without follow-up MRI (n=10)	p*
Male	35 (90)	22 (96)	27 (93)	8 (80)	0.27
Age, yrs	59.5 ± 12.7	60.4 ± 12.4	59.2 ± 13.2	60.6 ± 11.7	0.76
Infarct vessel
LM	1 (3)	0 (0)	1 (3)	0 (0)	1.00
LAD	21 (54)	12 (52)	15 (52)	6 (60)
RCX	5 (13)	1 (4)	4 (14)	1 (10)
RCA	12 (31)	10 (43)	9 (31)	3 (30)
No. of diseased vessels	2.1 ± 0.9	2.2 ± 0.9	2.1 ± 0.9	2.0 ± 0.9	0.75
1-vessel disease	13 (33)	7 (30)	9 (31)	4 (40)	0.90
2-vessel-disease	10 (26)	5 (22)	8 (28)	2 (20)
3-vessel-disease	16 (41)	11 (48)	12 (41)	4 (40)
Presence of non-culprit lesions requiring PCI	19 (49)	12 (52)	15 (52)	4 (40)	0.72
LVEF, %	46 ± 11	45 ± 13	47 ± 10	43 ± 15	0.27
Pain-to-balloon time, hrs	8.3 ± 10.5 [1.5 – 55.7]	7.8 ± 12.5 [1.5 – 55.7]	9.3 ± 11.7 [2.1 – 55.7]	5.5 ± 4.9 [1.5 – 16.9]	0.35
Pain-to-scan time, hrs	130.5 ± 36.4 [73.5 – 217.3]	119.9 ± 33.9 [73.5 – 202.1]	124.9 ± 33.9 [73.5 – 209.3]	141.4 ± 40.4 [97.7 – 217.3]	0.24
Balloon-to-scan time, hrs	123.5 ± 35.8 [68.5 – 214.0]	115.1 ± 34.5 [68.5 – 193.8]	117.5 ± 33.3 [68.5 – 193.8]	136.7 ± 38.6 [94.3 – 214.0]	0.14
CK max, U/l	2292 ± 1955	2303 ± 2295	2450 ± 2055	1833 ± 1640	0.40
CKMB max, U/l	262 ± 183	261 ± 214	271 ± 199	235 ± 128	0.62
TnT max, ng/ml	3.6 ± 4.3	4.5 ± 5.3	3.8 ± 4.7	3.1 ± 3.0	0.69
Maximum leukocyte count, G/l	13.1 ± 4.2	12.5 ± 3.3	12.8 ± 3.2	14.0 ± 6.4	0.44
at day	0.6 ± 0.8	0.4 ± 0.6	0.4 ± 0.6	1.2 ± 1.0	<0.001
Maximum monocyte count, G/l	1.2 ± 0.5	1.1 ± 0.3	1.2 ± 0.4	1.4 ± 0.5	0.16
at day	1.8 ± 1.1	1.7 ± 1.0	1.8 ± 1.1	1.7 ± 0.8	0.85

Values are n (%) or mean ± SD.

^*p-values for patients with follow-up MRI vs. patients without follow-up MRI